These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3706317)

  • 21. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins.
    Lautenbach E; LaRosa LA; Marr AM; Nachamkin I; Bilker WB; Fishman NO
    Clin Infect Dis; 2003 Feb; 36(4):440-6. PubMed ID: 12567301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost and quality considerations in antibiotic formulary management.
    Ritchie DF
    Pharm Pract Manag Q; 1996 Jul; 16(2):4-8. PubMed ID: 10161610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulary evaluation of second-generation cephamycin derivatives using decision analysis.
    Barriere SL
    Am J Hosp Pharm; 1991 Oct; 48(10):2146-50. PubMed ID: 1781469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug usage review of cefamandole at a teaching hospital.
    Zaremba CD; Bachand RL; Chow AW; Jewesson PJ
    Can J Hosp Pharm; 1988 Aug; 41(4):195-99, 214. PubMed ID: 10288851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
    Foster DR; Rhoney DH
    Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors potentially influencing aminoglycoside use and expenditure.
    DiPiro JT; Kilsdonk GF; Amerson AB; Record KE
    Am J Hosp Pharm; 1982 Jul; 39(7):1180-3. PubMed ID: 7114060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic therapy 1985: what are the challenges?
    Cohen MS
    Hosp Formul; 1985 Dec; 20(12):1247-8. PubMed ID: 10311346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety evaluation of cephalosporins based on utilization and adverse drug events: analysis of two databases in China.
    Ren X; Liu D; Ding N; Huang K; Xiong Y; Du G; Zeng F
    Expert Opin Drug Saf; 2012 Sep; 11(5):689-97. PubMed ID: 22708900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital anaerobic susceptibility testing: an aid to formulary decision making.
    Lebar WD; Moody SB; Burnakis TG
    Hosp Formul; 1990 Jul; 25(7):746-8, 750-1. PubMed ID: 10105471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale and experience in treating suspected hospital-based mixed infections.
    Billeter M
    Pharmacotherapy; 1995; 15(1 Pt 2):22S-26S. PubMed ID: 7753688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.
    Owens RC; Ambrose PG
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):77S-83S. PubMed ID: 17292579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of antimicrobial use and the impact of antimicrobial use guidelines in a small animal veterinary teaching hospital: 1995-2004.
    Weese JS
    J Am Vet Med Assoc; 2006 Feb; 228(4):553-8. PubMed ID: 16478430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the microbiology laboratory in guiding formulary decisions.
    Stratton CW
    Hosp Formul; 1988 Aug; 23(8):654-7. PubMed ID: 10312591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial formulary management: a consultant's perspective.
    Holzman MS
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):14S-18S. PubMed ID: 2011568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restricted cephalosporin use in teaching hospitals.
    Johnson PN; Jeffrey LP
    Am J Hosp Pharm; 1981 Apr; 38(4):513-7. PubMed ID: 7282677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.